Abstract
Objectives: There is a growing body of evidence that in the absence of Chlamydia trachomatis and/or Neisseria gonorrhoeae, Mycoplasma genitalium and bacterial vaginosis (BV) are associated with cervicitis. We aimed to describe infections detected among cervicitis cases over a decade and establish how commonly M. genitalium and BV were detected among non-chlamydial/non-gonococcal cases to inform testing and treatment practices. Methods: We conducted a retrospective case-series to determine the number of cervicitis cases diagnosed with genital infections (C. trachomatis, N. gonorrhoeae, M. genitalium and BV) among women attending the largest public sexual health service in Australia from 2011 to 2021. We determined the proportion of cervicitis cases with one or more genital infections detected, and trends in testing and detection of each infection over time. Results: Over a decade 813 cervicitis cases were diagnosed; 421 (52%, 95%CI: 48%–55%) had no infection detected; 226/729 (31%, 95%CI: 28%–35%) had BV, 163/809 (20%, 95%CI: 17%–23%) C. trachomatis, 48/747 (6%, 95%CI: 5%–8%) M. genitalium, and 13/793 (2%, 95%CI: 1%–3%) N. gonorrhoeae. Of the 665 (82%) cases tested for all four infections, 268 (40%) had one infection and 73 (11%) had >1 infection detected. Of the 517/665 (78%) non-chlamydial/non-gonococcal cases, 164 (32%) had BV and 16 (3%) had M. genitalium as the sole infections detected; a further 13 cases (3%) were co-infected with BV and M. genitalium. The proportion of cases tested for BV (90%) did not change overtime, but detection increased from 32% to 45% (Ptrend < 0.001). The proportion of cases tested for M. genitalium increased from 84% in 2011 to 96% in 2019 (Ptrend = 0.006), with M. genitalium-detection in cervicitis increasing from 3% to 7% (Ptrend = 0.046). Conclusions: In our study population, chlamydia or gonorrhoea were not detected in ∼75% of cervicitis cases; 1 in 3 of these cases had BV and/or M. genitalium, and both increased in prevalence over time. These data highlight the need for clinicians to consider BV and M. genitalium when assessing and managing cervicitis.
| Original language | English |
|---|---|
| Article number | 1539186 |
| Number of pages | 9 |
| Journal | Frontiers in Reproductive Health |
| Volume | 7 |
| DOIs | |
| Publication status | Published - 2025 |
Keywords
- bacterial vaginosis
- cervicitis
- Chlamydia trachomatis
- Mycoplasma genitalium
- Neisseria gonorrhoeae
- sexually transmitted infections
Projects
- 3 Finished
-
A multidisciplinary approach to understanding the transmission dynamics and the control of sexually transmitted infections
Chow, E. (Primary Chief Investigator (PCI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/20 → 31/12/24
Project: Research
-
Improving treatment and control of drug resistant and refractory sexually transmitted infections
Bradshaw, C. (Primary Chief Investigator (PCI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/20 → 31/12/25
Project: Research
-
Optimising the control and management of sexually transmitted infections through research and innovation
Fairley, C. (Primary Chief Investigator (PCI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/20 → 31/12/25
Project: Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver